DFP has been successfully added to your Stock Email Alerts list.
You can manage your stock email alerts here.
DFP has been removed from your Stock Email Alerts list.
Please enter Portfolio Name for new portfolio.
Flaherty & Crumrine Pref&Inc Allocation's change in receivables for the quarter that ended in May. 2024 was $0.48 Mil. It means Flaherty & Crumrine Pref&Inc Allocation's Accounts Receivable declined by $0.48 Mil from Nov. 2023 to May. 2024 .
Flaherty & Crumrine Pref&Inc Allocation's change in receivables for the fiscal year that ended in Nov. 2023 was $0.60 Mil. It means Flaherty & Crumrine Pref&Inc Allocation's Accounts Receivable declined by $0.60 Mil from Nov. 2022 to Nov. 2023 .
Flaherty & Crumrine Pref&Inc Allocation's Accounts Receivable for the quarter that ended in May. 2024 was $0.00 Mil.
Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed. Flaherty & Crumrine Pref&Inc Allocation's Days Sales Outstanding for the six months ended in May. 2024 was 0.00.
In Ben Graham's calculation of liquidation value, Apple Inc's Accounts Receivable are only considered to be worth 75% of book value. Flaherty & Crumrine Pref&Inc Allocation's liquidation value for the six months ended in May. 2024 was $-279.53 Mil.
The historical data trend for Flaherty & Crumrine Pref&Inc Allocation's Change In Receivables can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Flaherty & Crumrine Pref&Inc Allocation Annual Data | ||||||||||||||||
Trend | Nov17 | Nov18 | Nov19 | Nov20 | Nov21 | Nov22 | Nov23 | |||||||||
Change In Receivables | Get a 7-Day Free Trial | 0.48 | -0.08 | -8.32 | -0.88 | 0.60 |
Flaherty & Crumrine Pref&Inc Allocation Semi-Annual Data | ||||||||||||||
Nov17 | May18 | Nov18 | May19 | Nov19 | May20 | Nov20 | May21 | Nov21 | May22 | Nov22 | May23 | Nov23 | May24 | |
Change In Receivables | Get a 7-Day Free Trial | 7.97 | -8.84 | 0.65 | -0.05 | 0.48 |
Change In Accounts Receivable relative to the previous period. It is any increase or decrease in the cash a company is owed by its customers.
Change In Receivables for the trailing twelve months (TTM) ended in May. 2024 adds up the semi-annually data reported by the company within the most recent 12 months, which was $0.44 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Flaherty & Crumrine Pref&Inc Allocation (NYSE:DFP) Change In Receivables Explanation
1. Accounts Receivable are created when a customer has received a product but has not yet paid for that product. Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.
Flaherty & Crumrine Pref&Inc Allocation's Days Sales Outstanding for the quarter that ended in May. 2024 is calculated as:
Days Sales Outstanding | |||||
= | Accounts Receivable | / | Revenue | * | Days in Period |
= | 0 | / | 44.448 | * | 91 |
= | 0.00 |
2. In Ben Graham's calculation of liquidation value, Flaherty & Crumrine Pref&Inc Allocation's accounts receivable are only considered to be worth 75% of book value:
Flaherty & Crumrine Pref&Inc Allocation's liquidation value for the quarter that ended in May. 2024 is calculated as:
Liquidation Value | |||||||
= | Cash, Cash Equivalents, Marketable Securities | - | Total Liabilities | + | (0.75 * Accounts Receivable) | + | (0.5 * Total Inventories) |
= | 0 | - | 279.525 | + | 0.75 * 0 | + | 0.5 * 0 |
= | -279.53 |
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Thank you for viewing the detailed overview of Flaherty & Crumrine Pref&Inc Allocation's Change In Receivables provided by GuruFocus.com. Please click on the following links to see related term pages.
Bradford S Stone | officer: CFO and Treasurer, other: Affiliate of Inv. Adviser | 47 MAPLE ST. SUITE 403, SUMMIT NJ 07901 |
Robert E Chadwick | officer: CFO, VP & Treasurer | 301 E COLORADO BLVD STE 720, PASADENA CA 91101 |
Robert F Wulf | director | 301 E. COLORADO BLVD., SUITE 720, PASADENA CA 91101 |
Chad Conwell | officer: CCO, VP and Secretary | 301 E. COLORADO BLVD., SUITE 720, PASADENA CA 91101 |
Robert M Ettinger | officer: President | 301 E COLORADO BLVD STE 720, PASADENA CA 91101 |
Morgan Gust | director | C/O COBIZ FINANCIAL INC., 821 SEVENTEENTH STREET, DENVER CO 80202 |
Donald F Crumrine | director, officer: Chief Executive Officer | 301 E COLORADO BLVD STE 720, PASADENA CA 91101 |
David Gale | director | 220 MONTGOMERY STREET, SUITE 426, SAN FRANCISCO CA 94104 |
Karen Hanovice Hogan | director | 301 EAST COLORADO BLVD, SUITE 720, PASADENA CA 91101 |
Laurie C Lodolo | officer: Asst-CompOfficer/Treas/Sec | 301 E. COLORADO BOULEVARD, SUITE 720, PASADENA CA 91101 |
Flaherty & Crumrine Inc | other: Investment Adviser | 301 E. COLORADO BLVD, SUITE 720, PASADENA CA 91101 |
Robert T. Flaherty | other: Affiliated person Inv. Adviser | 301 EAST COLORADO BOULEVARD, SUITE 720, PASADENA CA 91101 |
Disclaimers: GuruFocus.com is not operated by a broker or a dealer. It has an affiliated registered investment adviser, which serves as the subadviser to an exchange traded fund. This investment adviser does not provide advice to individual investors. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes provided by InterActive Data. Fundamental company data provided by Morningstar, updated daily.